Treace Medical Concepts Announces Updated Interim Data for Lapiplasty® and Adductoplasty® Clinical Studies at ACFAS Annual Meeting
Ponte Vedra, FL – Treace Medical Concepts, Inc. (Treace or the Company), a leading medical technology company specializing in the surgical treatment of bunions and related midfoot deformities, recently unveiled updated interim data from its ALIGN3D™ and Mini3D™ Lapiplasty® clinical studies and presented the first data from the MTA3D™ Adductoplasty® clinical study at the 2025 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting in Phoenix, Arizona.
Lapiplasty® Procedures: ALIGN3D™ and Mini3D™
The ALIGN3D™ and Mini3D™ Lapiplasty® clinical studies aim to assess the safety, effectiveness, and patient satisfaction with the Lapiplasty® procedure for the correction of hallux valgus (bunion) deformities. The updated interim data, which includes a total of 1,500 patients across both studies, revealed:
- Significant improvement in hallux valgus angle reduction (average 22.4° and 22.6° for ALIGN3D™ and Mini3D™, respectively)
- High patient satisfaction rates (95.3% and 94.3% for ALIGN3D™ and Mini3D™, respectively)
- Minimal complications and adverse events
Adductoplasty® Procedure: MTA3D™
The MTA3D™ Adductoplasty® clinical study is designed to evaluate the safety and effectiveness of the Adductoplasty® procedure for the correction of adductovarus (flatfoot) deformities. The initial data presentation included:
- Significant improvement in adduction angle reduction (average 11.3°)
- Positive patient feedback and satisfaction
- Minimal complications and adverse events
Impact on Individuals and the World
For individuals, these advances in bunion and flatfoot correction procedures offer several potential benefits:
- Reduced recovery time and improved outcomes
- Minimal scarring and less invasive procedures
- Long-term correction and prevention of deformity progression
On a global scale, Treace Medical Concepts’ continued innovation in the field of foot and ankle surgery could lead to:
- Improved quality of life for millions of people suffering from bunion and flatfoot deformities
- Cost savings for healthcare systems by reducing the need for multiple procedures and extended hospital stays
- Expansion of Treace’s presence in the global medical technology market
Conclusion
Treace Medical Concepts’ latest clinical study data presented at the 2025 ACFAS Annual Meeting showcases the safety, effectiveness, and patient satisfaction of the Lapiplasty® and Adductoplasty® procedures for the correction of bunion and flatfoot deformities. These advancements have the potential to significantly improve the lives of individuals and contribute to cost savings for healthcare systems. As Treace continues to innovate in the field of foot and ankle surgery, the future looks promising for those seeking long-term correction and prevention of deformities.
For more information about Treace Medical Concepts and its innovative surgical solutions, please visit
